The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

The impact of the survivorship care plan on health care use : 2-year follow-up results of the ROGY care trial. / Jeppesen, Mette Moustgaard; Ezendam, Nicole P M; Pijnenborg, Johanna M A; Caroline Vos, M; Boll, Dorry; Kruitwagen, Roy F P M; Jensen, Pernille Tine; van de Poll-Franse, Lonneke V.

I: Journal of Cancer Survivorship, Bind 12, Nr. 1, 02.2018, s. 18-27.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Jeppesen, MM, Ezendam, NPM, Pijnenborg, JMA, Caroline Vos, M, Boll, D, Kruitwagen, RFPM, Jensen, PT & van de Poll-Franse, LV 2018, 'The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial', Journal of Cancer Survivorship, bind 12, nr. 1, s. 18-27. https://doi.org/10.1007/s11764-017-0639-7

APA

Jeppesen, M. M., Ezendam, N. P. M., Pijnenborg, J. M. A., Caroline Vos, M., Boll, D., Kruitwagen, R. F. P. M., Jensen, P. T., & van de Poll-Franse, L. V. (2018). The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial. Journal of Cancer Survivorship, 12(1), 18-27. https://doi.org/10.1007/s11764-017-0639-7

CBE

Jeppesen MM, Ezendam NPM, Pijnenborg JMA, Caroline Vos M, Boll D, Kruitwagen RFPM, Jensen PT, van de Poll-Franse LV. 2018. The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial. Journal of Cancer Survivorship. 12(1):18-27. https://doi.org/10.1007/s11764-017-0639-7

MLA

Vancouver

Jeppesen MM, Ezendam NPM, Pijnenborg JMA, Caroline Vos M, Boll D, Kruitwagen RFPM o.a. The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial. Journal of Cancer Survivorship. 2018 feb;12(1):18-27. https://doi.org/10.1007/s11764-017-0639-7

Author

Jeppesen, Mette Moustgaard ; Ezendam, Nicole P M ; Pijnenborg, Johanna M A ; Caroline Vos, M ; Boll, Dorry ; Kruitwagen, Roy F P M ; Jensen, Pernille Tine ; van de Poll-Franse, Lonneke V. / The impact of the survivorship care plan on health care use : 2-year follow-up results of the ROGY care trial. I: Journal of Cancer Survivorship. 2018 ; Bind 12, Nr. 1. s. 18-27.

Bibtex

@article{04a015a2d6774b9485b24352abb35aa2,
title = "The impact of the survivorship care plan on health care use: 2-year follow-up results of the ROGY care trial",
abstract = "PURPOSE: The purpose of this paper was to assess the impact of survivorship care plan (SCP) provision and moderating factors on health care use following endometrial cancer treatment.METHODS: Women newly diagnosed with endometrial cancer were included in a pragmatic cluster randomized trial at 12 hospitals in the Netherlands and were randomly assigned to SCP or usual care (n = 221; 75% response). The SCP was generated using the web-based Registrationsystem Oncological GYnecology (ROGY) and provided tailored information regarding disease, treatment, and possible late-effects. Cancer-related use of general practitioner, specialist, and additional health care was collected through questionnaires after diagnosis and at 6-, 12-, and 24-month follow-up and compared using linear multilevel regression analyses.RESULTS: Women who received an SCP had more cancer-related primary care visits compared to the usual care arm during the first year after diagnosis (β = 0.7, p < 0.01). At 6-month follow-up, women in the SCP group used more additional health care compared to women receiving usual care (24 vs. 11%, p = 0.04). Women with anxious symptoms (p = 0.03) and women who received radiotherapy (p = 0.01) had a higher primary care use within the first year after treatment, when receiving an SCP.CONCLUSIONS: The SCP increases primary health care consumption the first year after treatment, particularly in women treated with radiotherapy and women with anxious symptoms.IMPLICATIONS FOR CANCER SURVIVORS: These findings imply that the SCP enables women in need of supportive care to seek relevant care at an early stage after treatment. Whether this results in improved patient-reported outcomes in the long-term needs to be further studied.",
keywords = "Adult, Aged, Delivery of Health Care/standards, Endometrial Neoplasms/mortality, Female, Follow-Up Studies, Humans, Middle Aged, Surveys and Questionnaires, Survivorship",
author = "Jeppesen, {Mette Moustgaard} and Ezendam, {Nicole P M} and Pijnenborg, {Johanna M A} and {Caroline Vos}, M and Dorry Boll and Kruitwagen, {Roy F P M} and Jensen, {Pernille Tine} and {van de Poll-Franse}, {Lonneke V}",
year = "2018",
month = feb,
doi = "10.1007/s11764-017-0639-7",
language = "English",
volume = "12",
pages = "18--27",
journal = "Journal of Cancer Survivorship",
issn = "1932-2259",
publisher = "Springer New York LLC",
number = "1",

}

RIS

TY - JOUR

T1 - The impact of the survivorship care plan on health care use

T2 - 2-year follow-up results of the ROGY care trial

AU - Jeppesen, Mette Moustgaard

AU - Ezendam, Nicole P M

AU - Pijnenborg, Johanna M A

AU - Caroline Vos, M

AU - Boll, Dorry

AU - Kruitwagen, Roy F P M

AU - Jensen, Pernille Tine

AU - van de Poll-Franse, Lonneke V

PY - 2018/2

Y1 - 2018/2

N2 - PURPOSE: The purpose of this paper was to assess the impact of survivorship care plan (SCP) provision and moderating factors on health care use following endometrial cancer treatment.METHODS: Women newly diagnosed with endometrial cancer were included in a pragmatic cluster randomized trial at 12 hospitals in the Netherlands and were randomly assigned to SCP or usual care (n = 221; 75% response). The SCP was generated using the web-based Registrationsystem Oncological GYnecology (ROGY) and provided tailored information regarding disease, treatment, and possible late-effects. Cancer-related use of general practitioner, specialist, and additional health care was collected through questionnaires after diagnosis and at 6-, 12-, and 24-month follow-up and compared using linear multilevel regression analyses.RESULTS: Women who received an SCP had more cancer-related primary care visits compared to the usual care arm during the first year after diagnosis (β = 0.7, p < 0.01). At 6-month follow-up, women in the SCP group used more additional health care compared to women receiving usual care (24 vs. 11%, p = 0.04). Women with anxious symptoms (p = 0.03) and women who received radiotherapy (p = 0.01) had a higher primary care use within the first year after treatment, when receiving an SCP.CONCLUSIONS: The SCP increases primary health care consumption the first year after treatment, particularly in women treated with radiotherapy and women with anxious symptoms.IMPLICATIONS FOR CANCER SURVIVORS: These findings imply that the SCP enables women in need of supportive care to seek relevant care at an early stage after treatment. Whether this results in improved patient-reported outcomes in the long-term needs to be further studied.

AB - PURPOSE: The purpose of this paper was to assess the impact of survivorship care plan (SCP) provision and moderating factors on health care use following endometrial cancer treatment.METHODS: Women newly diagnosed with endometrial cancer were included in a pragmatic cluster randomized trial at 12 hospitals in the Netherlands and were randomly assigned to SCP or usual care (n = 221; 75% response). The SCP was generated using the web-based Registrationsystem Oncological GYnecology (ROGY) and provided tailored information regarding disease, treatment, and possible late-effects. Cancer-related use of general practitioner, specialist, and additional health care was collected through questionnaires after diagnosis and at 6-, 12-, and 24-month follow-up and compared using linear multilevel regression analyses.RESULTS: Women who received an SCP had more cancer-related primary care visits compared to the usual care arm during the first year after diagnosis (β = 0.7, p < 0.01). At 6-month follow-up, women in the SCP group used more additional health care compared to women receiving usual care (24 vs. 11%, p = 0.04). Women with anxious symptoms (p = 0.03) and women who received radiotherapy (p = 0.01) had a higher primary care use within the first year after treatment, when receiving an SCP.CONCLUSIONS: The SCP increases primary health care consumption the first year after treatment, particularly in women treated with radiotherapy and women with anxious symptoms.IMPLICATIONS FOR CANCER SURVIVORS: These findings imply that the SCP enables women in need of supportive care to seek relevant care at an early stage after treatment. Whether this results in improved patient-reported outcomes in the long-term needs to be further studied.

KW - Adult

KW - Aged

KW - Delivery of Health Care/standards

KW - Endometrial Neoplasms/mortality

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Middle Aged

KW - Surveys and Questionnaires

KW - Survivorship

U2 - 10.1007/s11764-017-0639-7

DO - 10.1007/s11764-017-0639-7

M3 - Journal article

C2 - 28875470

VL - 12

SP - 18

EP - 27

JO - Journal of Cancer Survivorship

JF - Journal of Cancer Survivorship

SN - 1932-2259

IS - 1

ER -